Clarithromycin
Clarithromycin is a macrolide antibiotic used to treat mild to moderate bacterial infections of the lungs, sinuses, throat, skin and ears, certain mycobacterial infections in people with advanced HIV, and H. pylori infection linked to duodenal ulcers.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 51 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
Clarithromycin is a macrolide antibiotic, on the market since about 1991 and available as a generic, used only against bacterial infections of the lungs, sinuses, throat, skin and ears and in combination treatment for H. pylori, the stomach bacterium linked to duodenal ulcers. It is a familiar option for people who cannot take penicillin. Most people tolerate it reasonably well, and the usual complaints are stomach upset, diarrhea and a bitter, lingering taste. The real watch-out is interactions, because it boosts the effects of many other medicines and can affect heart rhythm (QT prolongation) and the liver, so give your pharmacist your full medication list.
Clinical pearls
- Extended-release tablets are taken once daily with food and must be swallowed whole, never chewed, broken or crushed.
- Simvastatin and lovastatin must never be combined with clarithromycin because of serious muscle damage, so flag any statin before starting.
- Colchicine for gout and warfarin both become riskier with it, so expect dose changes or extra INR blood checks.
- Yellow skin or eyes, dark urine or a tender belly can signal liver injury, so stop it and call your doctor.
Patient information guide A plain-language walkthrough of Clarithromycin, written from its FDA label.
What Clarithromycin is used for
▾
Clarithromycin is used for mild to moderate infections caused by susceptible bacteria.
- Flare-ups of chronic bronchitis caused by bacteria (adults)
- Acute sinus infection (maxillary sinusitis)
- Community-acquired pneumonia
- Strep throat and tonsillitis, as an alternative when first-line treatment cannot be used (tablets and oral suspension)
- Uncomplicated skin and skin structure infections (tablets and oral suspension)
- Middle ear infection (acute otitis media) in children (tablets and oral suspension)
- Treatment and prevention of disseminated Mycobacterium avium complex infection in people with advanced HIV (tablets and oral suspension)
- H. pylori infection and duodenal ulcer disease in adults, in combination with other drugs (tablets only)
- Extended-release tablets are approved only for chronic bronchitis flare-ups, sinus infection and community-acquired pneumonia in adults
How Clarithromycin works
▾
Clarithromycin is a macrolide antibiotic. It acts against susceptible bacteria and spreads well into tissues, where it can reach higher levels than in the blood.
Some bacteria, including certain Streptococcus pneumoniae and Staphylococcus aureus, are resistant to macrolides. Your doctor may order testing when needed.
Clarithromycin dosage
▾
Clarithromycin is taken by mouth as tablets, extended-release tablets, or a liquid suspension. Tablets and suspension are usually taken every 12 hours, while extended-release tablets are taken once daily.
- Tablets can be taken with or without food.
- Extended-release tablets should be taken with food and swallowed whole.
- Follow your prescriber's directions for how much to take and for how long. Complete the course as prescribed.
Dosing details from the FDA-approved label
From the Clarithromycin prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
- Acute bacterial exacerbation of chronic bronchitis (adults)
- 250 to 500 mg every 12 hours for 7-14 days
- For M. catarrhalis and S. pneumoniae use 250 mg; for H. influenzae and H. parainfluenzae use 500 mg; for H. parainfluenzae duration is 7 days
- Acute maxillary sinusitis (adults)
- 500 mg every 12 hours for 14 days
- Community-acquired pneumonia (adults)
- 250 mg every 12 hours for 7-14 days
- For H. influenzae the duration is 7 days; for H. parainfluenzae and M. catarrhalis use extended-release tablets only
- Pharyngitis/Tonsillitis (adults)
- 250 mg every 12 hours for 10 days
- Uncomplicated skin and skin structure infections (adults)
- 250 mg every 12 hours for 7-14 days
- H. pylori eradication with amoxicillin and omeprazole or lansoprazole (adults)
- 500 mg every 12 hours for 10-14 days (500 mg clarithromycin with 30 mg lansoprazole and 1 gram amoxicillin every 12 hours for 10 or 14 days
- Or with 20 mg omeprazole and 1 gram amoxicillin every 12 hours for 10 days)
- With an ulcer present at start, an additional 18 days of omeprazole 20 mg once daily is recommended with the omeprazole triple therapy
- H. pylori eradication with omeprazole, dual therapy (adults)
- 500 mg clarithromycin every 8 hours with 40 mg omeprazole once every morning for 14 days
- An additional 14 days of omeprazole 20 mg once daily is recommended for ulcer healing and symptom relief
- Mycobacterial infections, treatment and prophylaxis (adults)
- 500 mg every 12 hours
- Continue if clinical response is observed; use with other antimycobacterial drugs for MAC treatment
- Pediatric patients
- 15 mg/kg/day divided every 12 hours for 10 days
- Maximum: up to the adult dose
- Mycobacterial infections, treatment and prophylaxis (pediatric patients)
- 7.5 mg/kg every 12 hours
- Maximum: 500 mg every 12 hours
Read the label’s full dosing text
2 DOSAGE AND ADMINISTRATION Adults: clarithromycin 250 mg or 500 mg every 12 hours for 7–14 days (2.2) Adults: H. pylori eradication (in combination with lansoprazole/amoxicillin, omeprazole/amoxicillin, or omeprazole): clarithromycin 500 mg every 8 or 12 hours for 10–14 days. See full prescribing information (FPI) for additional information. (2.3) Pediatric Patients: clarithromycin 15 mg/kg/day divided every 12 hours for 10 days (2.4) Mycobacterial Infections: clarithromycin 500 mg every 12 hours; clarithromycin 7.5 mg/kg up to 500 mg every 12 hours in pediatric patients (2.5) Reduce dose in moderate renal impairment with concomitant atazanavir or ritonavir-containing regimens and in severe renal impairment (2.6) 2.1 Important Administration Instructions Clarithromycin tablets may be given with or without food. 2.2 Adult Dosage The recommended dosages of clarithromycin for the treatment of mild to moderate infections in adults are listed in Table 1. Table 1. Adult Dosage Guidelines Clarithromycin tablets Infection Dosage (every 12 hours) Duration (days) Acute bacterial exacerbation of chronic bronchitis 250 to 500 mg a 7 b -14 Acute maxillary sinusitis 500 mg 14 Community-acquired pneumonia 250 mg c 7 d -14 Pharyngitis/Tonsillitis 250 mg 10 Uncomplicated skin and skin structure infections 250 mg 7-14 Treatment and prophylaxis of disseminated Mycobacterium avium disease [see Dosage and Administration (2.5) ] 500 mg e - H.pylori eradication to reduce the risk of duodenal ulcer recurrence with amoxicillin and omeprazole or lansoprazole [see Dosage and Administration (2.3) ] 500 mg 10-14 H.pylori eradication to reduce the risk of duodenal ulcer recurrence with omeprazole [see Dosage and Administration (2.3) ] 500 mg every 8 hours 14 a For M. catarrhalis and S. pneumoniae use 250 mg. For H. influenzae and H. parainfluenzae , use 500 mg. b For H. parainfluenzae , the duration of therapy is 7 days. c For H. parainfluenzae and M. catarrhalis use clarithromycin extended-release tablets only. d For H. influenzae , the duration of therapy is 7 days. e Clarithromycin therapy should continue if clinical response is observed. Clarithromycin can be discontinued when the patient is considered at low risk of disseminated infection. 2.3 Combination Dosing Regimens for H.
Excerpted — the section continues on the label. Read the full Dosage and Administration section on DailyMed →
Clarithromycin side effects
▾
The most common side effects involve the digestive system and taste.
Common side effects
- Abdominal pain
- Diarrhea
- Nausea
- Vomiting
- Altered or bad taste (dysgeusia)
- Indigestion
- Headache
- Rash
- Abnormal liver tests and yeast infections (candidiasis) have also been reported
When to get medical help
- Get emergency help for signs of a severe allergic reaction, such as trouble breathing, swelling, or a severe blistering skin rash.
- Call your doctor right away if you have signs of liver problems: loss of appetite, yellow skin or eyes, dark urine, itching, or a tender belly.
- Seek help if you have a racing, pounding or irregular heartbeat, or you faint. Clarithromycin can affect heart rhythm (QT prolongation).
- Call your doctor if you have diarrhea that is severe, watery or bloody. This can happen during treatment or even up to two months after it ends.
- Tell your doctor if you have myasthenia gravis and your muscle weakness gets worse.
- Seek help if you take colchicine and develop signs of toxicity. Interactions can be life-threatening.
Clarithromycin warnings and precautions
▾
- Drug interactions can be serious and even fatal. Several medicines must not be combined with clarithromycin.
- Heart rhythm: it can prolong the QT interval and cause dangerous arrhythmias. Older adults may be more susceptible.
- Liver: hepatitis and liver failure have been reported. Stop and call your doctor if symptoms appear.
- Allergic reactions: severe reactions, including skin reactions like Stevens-Johnson syndrome, require stopping the drug immediately.
- C. difficile diarrhea can occur during or up to two months after treatment.
- Myasthenia gravis symptoms may worsen.
- Pregnancy: avoid unless there is no alternative.
Clarithromycin interactions
▾
Clarithromycin strongly inhibits an enzyme (CYP3A4) that breaks down many medicines, so levels of other drugs can rise.
- Cisapride, pimozide, ergot medicines, lomitapide, lurasidone, lovastatin and simvastatin: contraindicated
- Colchicine: life-threatening toxicity possible
- Warfarin: higher bleeding risk
- Diabetes medicines and insulin: low blood sugar
- Calcium channel blockers: low blood pressure and kidney injury
- Digoxin, theophylline, carbamazepine, quetiapine, and certain benzodiazepines: higher levels or stronger effects
- Sildenafil, tadalafil and vardenafil: not recommended together
- Rifampicin, rifabutin, efavirenz, nevirapine: may lower clarithromycin effectiveness
- QT-prolonging drugs and some heart rhythm medicines: avoid
Interactions listed in the FDA-approved label
From the Clarithromycin prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
- Theophylline: May increase serum theophylline concentrations. Consider monitoring serum theophylline concentrations in patients on high doses or with baseline concentrations in the upper therapeutic range.
- Verapamil: Hypotension, bradyarrhythmias, and lactic acidosis have been observed with concurrent use.
- Carbamazepine: Increases plasma concentrations of carbamazepine. Blood level monitoring of carbamazepine may be considered.
- Terfenadine: Plasma concentrations of the active acid metabolite of terfenadine were threefold higher on average. Concomitant administration is contraindicated.
- Omeprazole: Steady-state omeprazole concentrations increased (Cmax 30%, AUC0-24 89%, t½ 34%).
- Zidovudine: May decrease steady-state zidovudine concentrations. Administration of clarithromycin and zidovudine should be separated by at least two hours.
- Ritonavir: Clarithromycin AUC increased 77% and 14-OH clarithromycin AUC decreased 100%. Doses of clarithromycin greater than 1000 mg per day should not be co-administered with protease inhibitors; consider alternative antibacterial therapy for indications other than MAC.
- Oral anticoagulants: May potentiate the effects of the oral anticoagulants. Prothrombin times should be carefully monitored.
- Digoxin: Inhibition of Pgp may increase digoxin exposure, with reports of elevated serum concentrations and signs of digoxin toxicity including potentially fatal arrhythmias. Consider monitoring serum digoxin concentrations.
- Colchicine: Colchicine Cmax increased 197% and AUC0-∞ increased 239%. Reduce colchicine dose in patients with normal renal and hepatic function; contraindicated in patients with renal or hepatic impairment.
Read the label’s full interactions text
Drug Interactions Clarithromycin use in patients who are receiving theophylline may be associated with an increase of serum theophylline concentrations. Monitoring of serum theophylline concentrations should be considered for patients receiving high doses of theophylline or with baseline concentrations in the upper therapeutic range. In two studies in which theophylline was administered with clarithromycin (a theophylline sustained-release formulation was dosed at either 6.5 mg/kg or 12 mg/kg together with 250 or 500 mg q12h clarithromycin), the steady-state levels of C max , C min , and the area under the serum concentration time curve (AUC) of theophylline increased about 20%. Hypotension, bradyarrhythmias, and lactic acidosis have been observed in patients receiving concurrent verapamil, belonging to the calcium channel blockers drug class. Concomitant administration of single doses of clarithromycin and carbamazepine has been shown to result in increased plasma concentrations of carbamazepine. Blood level monitoring of carbamazepine may be considered. When clarithromycin and terfenadine were coadministered, plasma concentrations of the active acid metabolite of terfenadine were threefold higher, on average, than the values observed when terfenadine was administered alone. The pharmacokinetics of clarithromycin and the 14-OH-clarithromycin were not significantly affected by coadministration of terfenadine once clarithromycin reached steady-state conditions. Concomitant administration of clarithromycin with terfenadine is contraindicated (see CONTRAINDICATIONS ). Clarithromycin 500 mg every 8 hours was given in combination with omeprazole 40 mg daily to healthy adult subjects. The steady-state plasma concentrations of omeprazole were increased (C max , AUC 0-24 , and t ½ increases of 30%, 89%, and 34%, respectively), by the concomitant administration of clarithromycin.
Excerpted — the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before taking Clarithromycin
▾
- Allergy to clarithromycin, erythromycin or other macrolides
- Prior liver problems or jaundice from clarithromycin
- Heart rhythm problems, slow heartbeat, low potassium or magnesium
- Kidney or liver disease, especially with colchicine or certain other medicines
- Myasthenia gravis
- Pregnancy: use only if no alternative; breastfeeding: small amounts pass into milk
- Children under 6 months: safety and effectiveness not established
- Older adults: higher risk of heart rhythm effects
Clarithromycin overdose
▾
Too much clarithromycin can cause stomach symptoms such as abdominal pain, vomiting, nausea and diarrhea. Treatment is to remove unabsorbed drug and provide supportive care. Dialysis is not expected to lower clarithromycin levels much. If you suspect an overdose, contact poison control or emergency services.
How your body processes Clarithromycin
▾
Clarithromycin is absorbed quickly from the gut, and about half of a tablet dose reaches the bloodstream. Peak levels occur within a few hours. Food does not change how much is absorbed, which is why the tablets can be taken with or without food. It spreads into tissues, is converted to an active metabolite, and is cleared partly by the kidneys. Its half-life is roughly 3 to 7 hours depending on the dose.
How to store Clarithromycin
▾
Store at 20° to 25°C (68° to 77°F) . Dispense in a tight container as described in the USP. Protect from light.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Supplements & herbs that interact with Clarithromycin
196 supplements and herbal products have documented interactions with Clarithromycin in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 9
- Moderate · 146
- Minor · 41
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Clarithromycin has been associated with lower levels of 7 nutrients in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
- Higher significance · 6
- Moderate · 1
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
Clarithromycin: pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Clarithromycin — the kind of thing our pharmacy team would talk through with you at the counter.
What is clarithromycin used for?
▾
How should I take it?
▾
What side effects are normal?
▾
Can I take it with my other medicines?
▾
Is it safe in pregnancy or while breastfeeding?
▾
Is Clarithromycin available over the counter?
▾
When was Clarithromycin first available?
▾
Who makes Clarithromycin?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Clarithromycin on HelloPharmacist
Clarithromycin forms and strengths (how it comes)
Clarithromycin is available in 3 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Clarithromycin inactive ingredients by manufacturer.
Tablet
How this form is used
- Clarithromycin tablets treat mild to moderate infections of the lungs, sinuses, throat, skin and ears, and certain mycobacterial infections in people with advanced HIV.
- Clarithromycin tablets are also used with other drugs in adults to eradicate H. pylori in people with duodenal ulcer disease.
- Clarithromycin tablets may be taken with or without food.
- Clarithromycin tablets are generally taken every 12 hours for most infections; some H. pylori regimens differ. Follow your prescriber's directions.
Extended-release tablet
How this form is used
- Clarithromycin extended-release tablets are for adults only, for bacterial flare-ups of chronic bronchitis, acute sinus infection, and community-acquired pneumonia.
- Clarithromycin extended-release tablets should be taken with food.
- Swallow Clarithromycin extended-release tablets whole. Do not chew, break or crush them.
- Clarithromycin extended-release tablets are taken once every 24 hours.
Oral suspension
How this form is used
- Clarithromycin oral suspension treats mild to moderate infections of the lungs, sinuses, throat, skin and ears, and certain mycobacterial infections in people with advanced HIV.
- Clarithromycin oral suspension is not listed for H. pylori infection.
Clarithromycin on the U.S. market: products, makers and brands
How Clarithromycin appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
24 companies list 54 Clarithromycin product records with the FDA, mostly as tablet, extended-release tablet, oral suspension; the earliest marketing or approval year on record is 1991. Brand names on the directory include Biaxin Filmtab, Biaxin Granules, Biaxin XL Filmtab and 2 more; the rest are generics.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (11) · Pellet (1) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How widely Clarithromycin is used (Medicaid data)
A general measure of how commonly Clarithromycin is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Clarithromycin is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Clarithromycin prescribed? Of the 1,601 medications we measure, Clarithromycin ranks #483 by Medicaid prescriptions — more than 70% of them.
Utilization by Clarithromycin product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
clarithromycin 500 MG Oral Tablet Most dispensed
Summed across the 7 of 157 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197517
clarithromycin 50 MG/ML Oral Suspension
Summed across the 2 of 3 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 309322
clarithromycin 250 MG Oral Tablet
Summed across the 4 of 44 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197516
clarithromycin 25 MG/ML Oral Suspension
Summed across the 2 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 240741
24 HR clarithromycin 500 MG Extended Release Oral Tablet
Summed across the 2 of 7 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 359385
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Clarithromycin, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 17 of 213 listed Clarithromycin NDCs with Medicaid activity.
Compare Clarithromycin products
A representative set of FDA-listed product records for Clarithromycin — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Extended-release tablet | ||||
| 500 mg | Oral | Actavis Pharma, Inc. | ANDA | View NDC → |
| 500 mg | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 500 mg | Oral | Lannett Company, Inc. | ANDA | View NDC → |
| 500 mg | Oral | PD-Rx Pharmaceuticals, Inc. | ANDA | View NDC → |
| 500 mg | Oral | Solaris Pharma Corporation | ANDA | View NDC → |
| 💊Oral suspension | ||||
| 250 mg/5 mL | Oral | A-S Medication Solutions | ANDA | View NDC → |
| 125 mg/5 mL | Oral | Sandoz Inc | ANDA | View NDC → |
| 250 mg/5 mL | Oral | Sandoz Inc | ANDA | View NDC → |
| 💊Tablet | ||||
| 250 mg | Oral | A-S Medication Solutions | ANDA | View NDC → |
| 500 mg | Oral | A-S Medication Solutions × 2 listings | ANDA | View NDC → |
| 250 mg | Oral | Alembic Pharmaceuticals Inc. | ANDA | View NDC → |
| 500 mg | Oral | Alembic Pharmaceuticals Inc. | ANDA | View NDC → |
| 250 mg | Oral | Alembic Pharmaceuticals Limited | ANDA | View NDC → |
| 500 mg | Oral | Alembic Pharmaceuticals Limited | ANDA | View NDC → |
| 500 mg | Oral | American Health Packaging × 2 listings | ANDA | View NDC → |
| 500 mg | Oral | Asclemed USA, Inc. | ANDA | View NDC → |
| 250 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 500 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 250 mg | Oral | AvPAK | ANDA | View NDC → |
| 500 mg | Oral | AvPAK | ANDA | View NDC → |
| 500 mg | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 250 mg | Oral | Chartwell RX, LLC. | ANDA | View NDC → |
| 500 mg | Oral | Chartwell RX, LLC. | ANDA | View NDC → |
| 500 mg | Oral | Coupler LLC | ANDA | View NDC → |
| 500 mg | Oral | DirectRx | ANDA | View NDC → |
| 500 mg | Oral | Direct_Rx | ANDA | View NDC → |
| 250 mg | Oral | Lannett Company, Inc. | ANDA | View NDC → |
| 500 mg | Oral | Lannett Company, Inc. | ANDA | View NDC → |
| 500 mg | Oral | Major Pharmaceuticals | ANDA | View NDC → |
| 500 mg | Oral | Northwind Health Company, LLC × 2 listings | ANDA | View NDC → |
| 500 mg | Oral | NuCare Pharmaceuticals,Inc. | ANDA | View NDC → |
| 500 mg | Oral | PD-Rx Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| 500 mg | Oral | Preferred Pharmaceuticals Inc. | ANDA | View NDC → |
| 500 mg | Oral | Proficient Rx LP × 4 listings | ANDA | View NDC → |
| 500 mg | Oral | Remedyrepack Inc. | ANDA | View NDC → |
| 250 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 500 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 250 mg | Oral | Sandoz Inc | ANDA | View NDC → |
| 500 mg | Oral | Sandoz Inc | ANDA | View NDC → |
| 250 mg | Oral | Solaris Pharma Corporation | ANDA | View NDC → |
| 500 mg | Oral | Solaris Pharma Corporation | ANDA | View NDC → |
| 250 mg | Oral | Sportpharm LLC × 2 listings | ANDA | View NDC → |
| 500 mg | Oral | Sportpharm LLC × 2 listings | ANDA | View NDC → |
Showing 54 of 54 products — FDA National Drug Code Directory. See every product, package size and price: browse all 54 Clarithromycin NDCs →
Clarithromycin side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Clarithromycin — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Clarithromycin in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Clarithromycin FDA approval history
How Clarithromycin went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Clarithromycin recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Clarithromycin recalls since July 2021.
✅No Clarithromycin recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 21212 3 dose forms · 6 strengths
-
Dose form (SCDF) Extended Release Oral Tablet RxCUI 371541In current FDA listings -
Dose form (SCDF) Oral Suspension RxCUI 371539In current FDA listings -
Dose form (SCDF) Oral Tablet RxCUI 371540In current FDA listings
Look up RxCUI 21212 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Clarithromycin supply and shortage status
Whether Clarithromycin is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
💵 What Clarithromycin costs pharmacies (NADAC benchmark)
The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.
| Form | Strength | Pharmacy acquisition benchmark | |
|---|---|---|---|
| Tablet, Film Coated · Oral | 500 mg | $0.466 per tablet | NDC details & price history |
| Tablet, Film Coated · Oral | 250 mg | $0.394 per tablet | NDC details & price history |
| Tablet · Oral | 500 mg | $0.488 per tablet | NDC details & price history |
| Tablet · Oral | 250 mg | $0.371 per tablet | NDC details & price history |
| Tablet, Film Coated, Extended Release · Oral | 500 mg | $1.92 per tablet | NDC details & price history |
| For Suspension · Oral | 250 mg/5 mL | $1.35–$1.57 per mL | NDC details & price history |
| For Suspension · Oral | 125 mg/5 mL | $0.939–$0.950 per mL | NDC details & price history |
| Tablet, Film Coated | 250 mg | $0.394 per tablet | NDC details & price history |
| Tablet, Film Coated | 500 mg | $0.466 per tablet | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.
Clarithromycin brand names
Clarithromycin is sold under 5 brand names in the FDA directory — Biaxin Filmtab, Biaxin Granules, Biaxin XL Filmtab, Biaxin XL Pac and others. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Who makes Clarithromycin: manufacturers and labelers
24 companies list Clarithromycin products with the FDA. By number of product records, the largest are A-S Medication Solutions, PD-Rx Pharmaceuticals, Inc., Proficient Rx LP. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Clarithromycin drug class (RxNorm)
Clarithromycin belongs to the Macrolide Antimicrobial class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
Sources for this Clarithromycin page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. NuCare Pharmaceuticals, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →